These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Maternal serum activin A levels in association with intrauterine fetal growth restriction. Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273 [TBL] [Abstract][Full Text] [Related]
24. Doppler fetal circulation in pregnancies complicated by pre-eclampsia or delivery of a small for gestational age baby: 2. Longitudinal analysis. Harrington K; Thompson MO; Carpenter RG; Nguyen M; Campbell S Br J Obstet Gynaecol; 1999 May; 106(5):453-66. PubMed ID: 10430196 [TBL] [Abstract][Full Text] [Related]
25. Endothelin 1 and leptin in the pathophysiology of intrauterine growth restriction. Arslan M; Yazici G; Erdem A; Erdem M; Arslan EO; Himmetoglu O Int J Gynaecol Obstet; 2004 Feb; 84(2):120-6. PubMed ID: 14871513 [TBL] [Abstract][Full Text] [Related]
26. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Estellés A; Gilabert J; España F; Aznar J; Galbis M Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia. Wang HS; Lee JD; Cheng BJ; Soong YK Br J Obstet Gynaecol; 1996 Jul; 103(7):654-9. PubMed ID: 8688391 [TBL] [Abstract][Full Text] [Related]
28. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction. Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143 [TBL] [Abstract][Full Text] [Related]
29. Lupus anticoagulant in pre-eclampsia and intra-uterine growth retardation. Rafla N; Farquharson R Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42(3):167-70. PubMed ID: 1773868 [TBL] [Abstract][Full Text] [Related]
30. Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy. Heikinheimo M; Unnérus HA Obstet Gynecol; 1979 Nov; 54(5):606-10. PubMed ID: 315526 [TBL] [Abstract][Full Text] [Related]
31. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751 [TBL] [Abstract][Full Text] [Related]
32. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers. Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818 [TBL] [Abstract][Full Text] [Related]
33. Umbilical sP-selectin levels are different in preeclamptic pregnancies with intrauterine normal growth and growth restricted fetus. Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J J Matern Fetal Neonatal Med; 2011 Jun; 24(6):795-8. PubMed ID: 21534853 [TBL] [Abstract][Full Text] [Related]
34. Human placental lactogen in pre-eclampsia. Obiekwe BC; Sturdee D; Cockrill BL; Chard T Br J Obstet Gynaecol; 1984 Nov; 91(11):1077-80. PubMed ID: 6498121 [TBL] [Abstract][Full Text] [Related]
35. Increased levels of soluble corin in pre-eclampsia and fetal growth restriction. Miyazaki J; Nishizawa H; Kambayashi A; Ito M; Noda Y; Terasawa S; Kato T; Miyamura H; Shiogama K; Sekiya T; Kurahashi H; Fujii T Placenta; 2016 Dec; 48():20-25. PubMed ID: 27871468 [TBL] [Abstract][Full Text] [Related]
36. Fetal growth and placental function assessed by urinary estriol excretion before the onset of pre-eclampsia. Long PA; Abell DA; Beischer NA Am J Obstet Gynecol; 1979 Oct; 135(3):344-7. PubMed ID: 484623 [TBL] [Abstract][Full Text] [Related]
37. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction. Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491 [TBL] [Abstract][Full Text] [Related]
39. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women. Laskowska M; Laskowska K; Oleszczuk J J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708 [TBL] [Abstract][Full Text] [Related]
40. Fibrinogen concentration and factor VIII activity in women with preeclampsia. Williams VK; Griffiths AB; Carbone S; Hague WM Hypertens Pregnancy; 2007; 26(4):415-21. PubMed ID: 18066960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]